10.6 Biodiversity

Our Group-wide biodiversity position takes into account influences on biodiversity throughout the entire value chain. In this position, we commit ourselves to the United Nations Convention on Biological Diversity designates the variation within the workforce in terms of gender, origin, nationality, age, religion and physical capability. and its Nagoya Protocol, which regulates access to genetic resources and the fair and equitable sharing of the benefits arising from their utilization. Our CropScience subgroup passed an internal regulation in 2015 to ensure that the company only acquires and uses genetic resources in harmony with international and applicable national legislation.

Online annex: 3-10.6-1:

limited assurance

Biodiversity is essential for successful agriculture, as it promotes the resilience of ecosystems. Various ecological enhancement measures are under discussion to support resilient ecosystems, such as planting flower strips to provide a refuge for animals or the more extensive cultivation of slopes to protect against erosion. These measures can help farmers improve soil fertility and water regulation in their fields, or boost the pollination activities of insects and thus increase their yields.

HealthCare also attaches great importance to maintaining biological diversity. As a member of the Association of Research-Based Pharmaceutical Companies, it supports the association’s position on the U.N. Convention on Biological Diversity. Among other things, this policy, which applies to all HealthCare sites, takes into account that the subgroup concentrates on the chemical synthesis of substances using state-of-the-art technologies in medicinal, combinatorial and computational chemistry. Research into natural substances is not a focal point of its work, accounting for less than 5% of research projects. If such substances are used during research into new pharmaceuticals, they are first checked with respect to the Convention on Biological Diversity designates the variation within the workforce in terms of gender, origin, nationality, age, religion and physical capability. .

Group-wide directives stipulate that new production sites must not be set up in areas that are protected by statutory requirements of the countries concerned relating to natural characteristics, biodiversity or other factors.

Online annex: 3-10.6-2:

limited assurance

In 2013, Bayer Real Estate, the Bayer Group’s real estate service provider, used its global site register to compare the geographical coordinates of relevant production sites against those of internationally recognized protected areas (ASEAN Heritage, Barcelona Convention, UNESCO-MAB Biosphere Reserve, Wetlands and World Heritage Convention and Ramsar Convention). This comparison revealed three sites that are less than three kilometers from the protected areas Schorren van de Benenden Schelde, Belgium; the Wadden Sea of Lower Saxony, Germany; and Blesbokspruit, South Africa, respectively. Owing to major portfolio changes in the Group (separation of Covestro, formerly MaterialScience, sale of the Diabetes Care business and acquisition of the consumer care business of Merck & Co., Inc.) we are planning a new coordinate comparison with an updated range of production sites in 2016.